Key facts
- Commure’s last known valuation is $3.5B (Jan 2022).
- It has raised $789.7M; the latest was Later Stage VC ($200.0M) in Jun 2025.
- Notable investors include Y Combinator, Sequoia Capital, General Catalyst, Liquid 2 Ventures, 8VC — 25 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 25 names
- ·Watchlist + deal alerts for Commure
- ·The full record, as it builds
Funding rounds
No funding rounds for Commure are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Commure
Developer of a cloud-based interoperable platform designed to focus on accelerating healthcare software innovation. The company's platform unifies disparate datasets, surfaces meaningful insights, accelerates performance through a suite of applications, and enables seamless innovation across the healthcare industry, enabling healthcare providers, clinicians, and staff across care facilities to advance care through collaboration.
- Sector
- Healthcare
- HQ
- Mountain View, CA, United States
- Founded
- 2017
- Employees
- 1,518
- Website
- commure.com/
- Ownership
- Privately Held (backing)
Commure doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Commure shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Commure in its N-PORT filings yet. We sweep new filings monthly.